Want to join the conversation?
In 1Q16, $ESV expects depreciation to decline by approx. $35MM from $150MM in 4Q15 and G&A expense is expected to decline slightly from 4Q15 levels of $30MM. For 2016, Capex is expected to be $450MM, of which $275MM is for newbuild construction. The 2017 Capex budget is also $450MM. In 2018, Capex is expected to be $325MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?